Product Images Nifedipine

MEAN REDUCTIONS IN TROUGH SUPINE BLOOD PRESSURE (mmHg) for Nifedipine extended-release tablets for three different doses in two studies are shown. Study 1 and 2 both evaluated 30 mg, 60 mg, and 90 mg doses. In study 1, the reductions in trough supine blood pressure ranged from 53/2.9 to 12.5/8.1, while in study 2, the reductions ranged from 76/3.8 to 10.2/5.8. The placebo response was subtracted from the results.*

This is a table showing the incidence of adverse effects in patients taking Nifedipine extended-release tablets versus a placebo. The adverse effects listed include headache, flushing/heat sensation, dizziness, fatigue/asthenia, nausea, and constipation. The data is presented as percentages and based on a sample size of 370 for those taking Nifedipine and 126 for those taking the placebo.*

This is a description of three different strengths of medication produced by Novast. The 30mg tablets are yellow in color and have "Novast" on one side and "33" on the other side. The 60mg tablets are pink in color and have "Novast" on one side and "36" on the other side. The 90mg tablets are brown in color and have "Novast" on one side and "39" on the other side.*

This is a prescription drug label for a medication called NIFEdipine. It is an extended-release tablet used to treat high blood pressure. The label includes the drug's name, dosage, and safety information.*

This is a description for a bottle of NIFEdipine Extended-Release Tablets, USP containing 100 tablets. The lot number is 00000000 with an expiry date of 07/00. The NIFEdipine extended-release tablets are used to treat high blood pressure and angina (chest pain), and it is normally prescribed by a physician.*

This is a description of medication. The medication is NIFEdipine, in the form of extended-release tablets. The package contains 100 tablets. The rest of the text is not relevant or readable.*